Ned Pagliarulo's articles Biotechnology Novo takes big step toward ending Ozempic, Wegovy shortages All doses of the two drugs are now listed as available in the U.S., per an FDA database, although the company cautioned patients may still experience "variability" filling their prescriptions. Written by Ned Pagliarulo October 30, 2024October 30, 2024 Saving Bookmark this article Bookmarked Biotechnology Sanofi, expanding in radiopharma, strikes a joint venture deal The French drugmaker will invest 300 million euros into a new entity that will develop lead isotope-based therapies for cancer under the Orano Med brand. Written by Ned Pagliarulo October 17, 2024October 17, 2024 Saving Bookmark this article Bookmarked
Biotechnology Novo takes big step toward ending Ozempic, Wegovy shortages All doses of the two drugs are now listed as available in the U.S., per an FDA database, although the company cautioned patients may still experience "variability" filling their prescriptions. Written by Ned Pagliarulo October 30, 2024October 30, 2024 Saving Bookmark this article Bookmarked
Biotechnology Sanofi, expanding in radiopharma, strikes a joint venture deal The French drugmaker will invest 300 million euros into a new entity that will develop lead isotope-based therapies for cancer under the Orano Med brand. Written by Ned Pagliarulo October 17, 2024October 17, 2024 Saving Bookmark this article Bookmarked